Natural History and Management of Von Hippel-Lindau (VHL) Associated Pancreatic Neuroendocrine Tumors

NCT04074135 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

740

Enrollment

NIH

Sponsor class

Conditions

VHL Pancreatic Neuroendocrine Tumors
Von Hippel-Lindau Disease
Neuroendocrine Tumors

Interventions

DRUG: 68-Gallium DOTATATE

Sponsor

National Cancer Institute (NCI)